Literature DB >> 29344814

Nutritional therapy in autosomal dominant polycystic kidney disease.

Biagio R Di Iorio1, Adamasco Cupisti2, Claudia D'Alessandro2, Antonio Bellasi3, Vincenzo Barbera4, Luca Di Lullo4.   

Abstract

CKD-related nutritional therapy (NT) is a crucial cornerstone of CKD patients' treatment, but the role of NT has not been clearly investigated in autosomal dominant polycystic kidney disease (ADPKD). Several clinical studies have focused on new pharmacological approaches to delay cystic disease progression, but there are no data on dietary interventions in ADPKD patients. The aim of this paper is to analyze the evidence from the literature on the impact of five nutritional aspects (water, sodium, phosphorus, protein intake, and net acid load) in CKD-related ADPKD extrapolating-where information is unavailable-from what occurs in CKD non-ADPKD patients Sodium intake restriction could be useful in decreasing the growth rate of cysts. Although further evidence is needed, restriction of phosphorus and protein intake restriction represent cornerstones of the dietary support of renal non-ADPKD patients and common sense can guide their use. It could be also helpful to limit animal protein, increasing fruit and vegetables intake together with a full correction of metabolic acidosis. Finally, fluid intake may be recommended in the early stages of the disease, although it is not to be prescribed in the presence of moderate to severe reduction of renal function.

Entities:  

Keywords:  ADPKD; CKD; Fluid intake; Metabolic acidosis; Nutritional therapy; Phosphorus intake; Protein intake; Sodium intake

Mesh:

Substances:

Year:  2018        PMID: 29344814     DOI: 10.1007/s40620-018-0470-x

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  56 in total

1.  Increased water intake decreases progression of polycystic kidney disease in the PCK rat.

Authors:  Shizuko Nagao; Kazuhiro Nishii; Makoto Katsuyama; Hiroki Kurahashi; Tohru Marunouchi; Hisahide Takahashi; Darren P Wallace
Journal:  J Am Soc Nephrol       Date:  2006-06-28       Impact factor: 10.121

2.  Branched-chain amino acids enhance cyst development in autosomal dominant polycystic kidney disease.

Authors:  Junya Yamamoto; Saori Nishio; Fumihiko Hattanda; Daigo Nakazawa; Toru Kimura; Michio Sata; Minoru Makita; Yasunobu Ishikawa; Tatsuya Atsumi
Journal:  Kidney Int       Date:  2017-03-22       Impact factor: 10.612

3.  Effects of hydration in rats and mice with polycystic kidney disease.

Authors:  Katharina Hopp; Xiaofang Wang; Hong Ye; María V Irazabal; Peter C Harris; Vicente E Torres
Journal:  Am J Physiol Renal Physiol       Date:  2014-12-10

4.  Prognosis of adult onset polycystic kidney disease re-evaluated.

Authors:  D N Churchill; J C Bear; J Morgan; R H Payne; P J McManamon; M H Gault
Journal:  Kidney Int       Date:  1984-08       Impact factor: 10.612

5.  Early dietary protein restriction slows disease progression and lengthens survival in mice with polycystic kidney disease.

Authors:  K Tomobe; D Philbrick; H M Aukema; W F Clark; M R Ogborn; A Parbtani; H Takahashi; B J Holub
Journal:  J Am Soc Nephrol       Date:  1994-12       Impact factor: 10.121

6.  Dietary soy protein selectively reduces renal prostanoids and cyclooxygenases in polycystic kidney disease.

Authors:  Claudia Yu-Chen Peng; Deepa Sankaran; Malcolm R Ogborn; Harold M Aukema
Journal:  Exp Biol Med (Maywood)       Date:  2009-05-08

7.  A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate.

Authors:  Nimrit Goraya; Jan Simoni; Chan-Hee Jo; Donald E Wesson
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-07       Impact factor: 8.237

8.  High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III.

Authors:  Alex R Chang; Mariana Lazo; Lawrence J Appel; Orlando M Gutiérrez; Morgan E Grams
Journal:  Am J Clin Nutr       Date:  2013-11-13       Impact factor: 7.045

9.  Patient Survey of current water Intake practices in autosomal dominant Polycystic kidney disease: the SIPs survey.

Authors:  Ragada El-Damanawi; Tess Harris; Richard N Sandford; Fiona E Karet Frankl; Thomas F Hiemstra
Journal:  Clin Kidney J       Date:  2017-02-17

10.  Does increased water intake prevent disease progression in autosomal dominant polycystic kidney disease?

Authors:  Eiji Higashihara; Kikuo Nutahara; Mitsuhiro Tanbo; Hidehiko Hara; Isao Miyazaki; Kuninori Kobayashi; Toshiaki Nitatori
Journal:  Nephrol Dial Transplant       Date:  2014-04-15       Impact factor: 5.992

View more
  7 in total

Review 1.  The role of the intestinal microbiota in uremic solute accumulation: a focus on sulfur compounds.

Authors:  Alessandra F Perna; Griet Glorieux; Miriam Zacchia; Francesco Trepiccione; Giovanna Capolongo; Carmela Vigorito; Evgeniya Anishchenko; Diego Ingrosso
Journal:  J Nephrol       Date:  2019-01-23       Impact factor: 3.902

Review 2.  ADPKD current management and ongoing trials.

Authors:  Francesca Testa; Riccardo Magistroni
Journal:  J Nephrol       Date:  2019-12-18       Impact factor: 3.902

3.  The association of endothelin-1 levels with renal survival in polycystic kidney disease patients.

Authors:  Ismail Kocyigit; Eray Eroglu; Ahmet Safa Kaynar; Derya Kocer; Seval Kargi; Gokmen Zararsiz; Ruslan Bayramov; Hakan Imamoglu; Murat Hayri Sipahioglu; Bulent Tokgoz; Munis Dundar; Oktay Oymak
Journal:  J Nephrol       Date:  2018-07-18       Impact factor: 3.902

4.  Dietary Interventions in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Lauren Pickel; Ioan-Andrei Iliuta; James Scholey; York Pei; Hoon-Ki Sung
Journal:  Adv Nutr       Date:  2021-11-10       Impact factor: 8.701

Review 5.  Cystic Kidney Diseases From the Adult Nephrologist's Point of View.

Authors:  Roman-Ulrich Müller; Thomas Benzing
Journal:  Front Pediatr       Date:  2018-03-22       Impact factor: 3.418

Review 6.  Chronic hyperkalemia in non-dialysis CKD: controversial issues in nephrology practice.

Authors:  Luca De Nicola; Luca Di Lullo; Ernesto Paoletti; Adamasco Cupisti; Stefano Bianchi
Journal:  J Nephrol       Date:  2018-06-07       Impact factor: 3.902

7.  Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study.

Authors:  Biagio R Di Iorio; Antonio Bellasi; Kalani L Raphael; Domenico Santoro; Filippo Aucella; Luciano Garofano; Michele Ceccarelli; Luca Di Lullo; Giovanna Capolongo; Mattia Di Iorio; Pasquale Guastaferro; Giovambattista Capasso
Journal:  J Nephrol       Date:  2019-10-09       Impact factor: 3.902

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.